![[Podcast] Trial Trailblazers: Behind clinical breakthroughs](https://imgproxy.divecdn.com/cr_gUY8HHfHKWVfM5mEkCyXB9OzVqKd0L_Zq5ZJQSoM/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlX1BvZGNhc3RfY292ZXIxMzQ2eDcyOV9SMi5wbmc=.webp)
Embattled Elevation becomes latest biotech to accept Concentra buyout offer
Elevation Oncology, which spent the spring fending off activist investor demands to wind down, has become the latest beleaguered biotech to take up the option of a buyout from Concentra Biosciences.
Elevation Oncology, which spent the spring fending off activist investor demands to wind down, has become the latest beleaguered biotech to take up the option of a buyout from Concentra Biosciences.
